Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2021-05-13 | 2021-05-14 | 139303 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2023-02-10 | 2023-03-23 | 184317 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2024-11-21 | 2024-11-27 | 243580 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2024-12-13 | 2025-03-28 | 245598 |
| LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1711 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Resolved | 2017-03-17 | 2017-05-10 | 3115 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Resolved | 2019-06-27 | 2025-04-25 | 87673 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Resolved | 2019-06-27 | 2025-04-25 | 87676 |
| METHOXISAL-C 1/2 | 325MG 400MG 32.4MG | TABLET | Actual shortage | 2017-04-25 | 2017-10-05 | 8017 |
| METHOXISAL-C 1/2 | 325MG 400MG 32.4MG | TABLET | Actual shortage | 2017-04-25 | 2017-10-05 | 8033 |
| METHOXISAL-C 1/4 | 325MG 400MG 16.2MG | TABLET | Actual shortage | 2017-04-25 | 2017-10-05 | 8041 |
| METHOXISAL-C 1/8 | 325MG 400MG 8MG | TABLET | Actual shortage | 2017-04-25 | 2017-10-05 | 8044 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1714 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 125MG | POWDER FOR SOLUTION | Actual shortage | 2017-03-13 | 2020-02-13 | 1720 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1724 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1729 |
| MITOMYCIN FOR INJECTION | 20MG | POWDER FOR SOLUTION | Resolved | 2018-05-11 | 2018-07-30 | 49124 |
| MITOMYCIN FOR INJECTION | 20MG | POWDER FOR SOLUTION | Actual shortage | 2018-11-01 | 2021-10-14 | 65987 |
| NEO-LARYNGOBIS | 135MG | SUPPOSITORY | Resolved | 2023-06-16 | 2023-10-03 | 195198 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |